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Introduction: HPV vaccination prevents cervical cancer, the fourth most common cancer among 
women worldwide. Measured HPV vaccine acceptability is often high but does it also lead to 
high uptake? 
Methodology: A cohort was set up assessing HPV vaccine acceptability and other health behav-
iour constructs before, and vaccine uptake after an HPV vaccination programme in Eldoret, 
Kenya. Focus groups shed light on the motivation for vaccine uptake or refusal. 
Results: Acceptability was high but was no strong predictor of uptake, and neither were the 
constructs of the Health Belief Model. Lack of information and fear of side effects were major 
barriers. Feeling uncomfortable to discuss cervical cancer hampered open communication.  
Discussion: Distrust towards new vaccines and the health system blocked translation from will-
ingness-to-vaccinate to actual uptake, as did organizational factors such as poor promotion.
Conclusion: Future research should include broader concepts such as vaccine hesitancy and 
factors beyond personal control in order to predict vaccine uptake.
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 Introduction 
Cervical cancer poses a serious health threat to sexually active women, especially in 
low and middle income countries (LMIC) where screening opportunities are often low 
and treatment remains inaccessible for most of the affected women. Primary prevention 
through human papillomavirus (HPV) vaccination may therefore provide a turning point 
in the battle against cervical cancer (Denny et al., 2014:1389-1398). However, prior to 
implementing large-scale vaccination programmes, several knowledge gaps need to be 
addressed. Therefore, formative research has been conducted measuring (hypothetical) 
acceptability and identifying potential barriers to successful implementation. In general, 
the vaccine is well accepted, with as main reported barriers costs and fear of side effects 
(Allen et al., 2010:4027-37). 
The introduction of the HPV vaccine gave indeed rise to many studies gauging the 
public's perspectives, often applying health behaviour theories such as the Health Be-
1 This is the report of PhD research carried out at Ghent University, under the supervision of Olivier Degomme 
and Kristien Michielsen.
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lief Model (HBM) to identify determinants of acceptability (i.e. susceptibility and severity 
of cervical cancer, barriers and benefits of the vaccine, self-efficacy, and cues to action) 
(Brewer & Fazekas, 2007:107-14). However, most of these studies took place in industri-
alized regions and did not measure HPV vaccine uptake. As such, several questions arise: 
1) Is the HPV vaccine acceptable in low-income countries, where it can have most impact, 
and are the determinants similar? 2) Does high acceptability always lead to high HPV vac-
cine uptake, i.e. the true outcome of interest? In order to answer these questions, a study 
with three objectives was set up. 
 Objectives
 − Objective 1: To determine the acceptability and subsequent uptake of the HPV 
vaccine in the context of an HPV pilot vaccination programme in Eldoret, Kenya.
 − Objective 2: To ascertain whether health behaviour theories can be effectively ap-
plied to predict HPV vaccination in Eldoret, Kenya.
 − Objective 3: To identify factors that influence successful introduction of an HPV 
vaccination programme in Eldoret, Kenya.
 Methodology 
A longitudinal study was rolled-out, with baseline and follow-up taking place be-
fore and after the implementation of an HPV vaccination effort. The programme freely 
offered the HPV vaccine to girl pupils of primary schools in Eldoret: the vaccine was 
administered in the referral hospital but promotion was done at school by teachers. A 
cohort of randomly selected mothers of these eligible girls was set up and invited to par-
ticipate twice in a quantitative interview regarding cervical cancer prevention. HPV vac-
cine acceptability was measured at baseline while uptake got reported at follow-up. This 
design allowed studying acceptability and uptake, including the relation between these 
two main outcomes. In addition, a qualitative component was implemented at follow-up, 
evaluating the programme from the perspective of key-informants.
 Results
The HPV vaccination programme took place from May 2012 until March 2013. Base-
line and follow-up data were collected two months before and after the programme, in 
March 2012 and May 2013, respectively. Of the 287 women interviewed in 2012, 89.2 per-
cent (256/287) agreed to be interviewed again the next year. Also focus group discussions 
were organized in May 2013, with fathers (3), teachers (4) and vaccinators (1). 
While acceptability of the HPV vaccine among the mothers was very high at base-
line (88 percent accepted), only 31 percent had eventually vaccinated their daughter, and 
51 percent reported that they had wanted to vaccinate but had missed the opportunity. 
Results showed that among this latter group, 55 percent had not received information 
regarding the whereabouts of the programme.
Finally, among those who had actively decided not to vaccinate (18 percent), 42 per-
cent mentioned fear of side effects as barrier and 31 percent said the partner opposed to 
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vaccinating the daughter against cervical cancer. In general, the majority of the partici-
pants reported that unknown side effects made them doubt about HPV vaccination and 
that they needed more information in order to make an informed decision. 
No strong relation was found between HPV vaccine acceptability and vaccination. 
Also with regard to the applicability of the Health Belief Model (HBM), no associations 
were found between the constructs and uptake, except for self-efficacy which positively 
influenced vaccination. The predictive value of the model did increase after adding a vari-
able reporting whether or not the mother had received adequate information; being well-
informed led to higher vaccine uptake.
The qualitative data revealed that teachers and fathers had poor knowledge regard-
ing cervical cancer and felt rather uncomfortable sharing information about it. This had 
also led to poor communication regarding the vaccination programme. Teachers also 
missed support of health care providers to address the questions of the parents as well 
as their own doubts. In general, HPV vaccination was not considered important given 
that cervical cancer was perceived as a consequence of a modern lifestyle with which the 
participants did not feel related. Finally, distrust towards (new) vaccines also hampered 
uptake: some thought it was an experiment while others had lost faith in vaccines dur-
ing previous vaccination experiences. Suspicion did however fade away after a couple of 
months, once the community was convinced about the safety of the vaccine.
 Discussion
HPV vaccine acceptability was not a strong predictor of vaccine uptake. The transla-
tion of intention into behaviour was mainly hampered because information about the 
vaccination programme did not reach all parents. Limited knowledge regarding HPV and 
cancer, and cultural taboos made it difficult for teachers and parents to discuss HPV vac-
cination (Perlman et al., 2014). Therefore, direct communication of health care provid-
ers with caregivers seems crucial as the former is better posted to discuss such topics. 
Moreover, failure of achieving such a contact moment did not only lead to poor uptake 
but also allowed the spread of rumours and doubts. Future programmes will need to have 
more attention for two-way communication, to address misbeliefs, as opposed to the 
top-down approach usually used.
So while HPV vaccine uptake was lower than expected (LaMontagne et al., 2011:821-
830B), mainly due to organizational reasons, HPV vaccine acceptability reported at 
baseline might have been overestimated because of several factors. First of all, given 
that awareness regarding cervical cancer and HPV vaccination is generally low in Kenya, 
some participants were probably overtaken by the new information which interfered with 
their estimation of intention, tending to overvalue (also partly due to social desirability). 
In addition, people may overestimate their intentions – especially since new behaviours 
barriers are hard to predict – or express a desire rather than a true plan of action. Finally, 
given the novelty of HPV vaccination, it is not always clear who will take the final decision 
and as reported by the women in the quantitative study, in the end many fathers had an 
important role in the decision-making. As a result, women were not in control of their 
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behaviour meaning that their intentions were no longer relevant as a predictor for the 
vaccination status of the daughter (Sheeran, 2011:1-36).
Taken all together, the poor vaccine uptake, due to promotional flaws, combined 
with the high reported acceptability led to an imbalance in the relation acceptability-up-
take which was mainly driven by low acceptability leading to non-uptake, rather than by 
acceptors fulfilling their own reported objectives.
Similar to acceptability, also the HBM constructs were poor determinants of uptake 
(Gerend & Shepherd, 2012:171-80). Given that these measurements only assess person-
al beliefs and attitudes, and given the above-mentioned importance of programmatic 
strategies, adding variables beyond the personal perspective, at the organizational level, 
might improve the predictive value of the theory. In addition, also the value of each of the 
constructs can be questioned. Regarding the absence of a correlation of uptake with se-
verity and susceptibility, this is not so surprising given the Kenyan context: access to high 
quality care is limited and diseases often remain untreated which makes them more life-
threatening. Especially (cervical) cancer is considered deadly. As such, perceiving cervical 
cancer as a threat is common and, consequently, does not distinguish those who vacci-
nate against HPV and those who do not. With regard to foreseen benefits and barriers, 
one can wonder how reliable people's estimates can be regarding the advantages and dis-
advantages of a new, unknown vaccine. By measuring users' and non-users' perspectives, 
more realistic determinants might be identified. Also trust in the vaccine or in the health 
system might be a stronger predictor, given that people rely on past, medical experiences. 
Also self-efficacy, which was positively associated with vaccine uptake, can be considered 
as trust, in oneself, to perform the desired behaviour (Carpenter, 2010:661-669).
By focusing promotion on increasing trust, but also by choosing a delivery platform 
that instils confidence and convenience, vaccine uptake could thus potentially increase. A 
carefully designed programme should indeed take into account vaccine confidence, com-
placency and convenience and address them by both tailored promotion and adequate 
vaccine delivery. In the context of the HPV vaccination programme in Eldoret however, 
none of the three C's seemed to be properly fulfilled (Larson et al., 2014: 2150-59): some 
people distrusted the vaccine and the health providers in the referral hospital, cervical 
cancer was not always seen as a threat (whereas the vaccine had potential side effects) 
and offering the vaccine in a health centre was not considered the most convenient ap-
proach. School-based vaccination seemed more preferred but good cooperation between 
health staff and the teachers corpse will be crucial to obtain good coverage (Paul & Fabio, 
2014:320-326).
 Conclusion
Measuring HPV vaccine acceptability and its determinants is not sufficient to predict 
uptake. More attention should go to other important factors such as vaccine confidence 
or more broadly, vaccine hesitancy. In addition, variables beyond personal control con-
tribute significantly to vaccine uptake pointing out the need to complement formative 
research – mostly conducted prior to implementation and based on personal health be-
haviour theories – with monitoring vaccination programmes and assessing users’ and 
non-users’ perspectives.
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